New Method Allows Scientists to 3D-Print Structures Within Cells

Why It Matters

Embedding functional microstructures inside cells opens new avenues for probing cellular mechanics and engineering synthetic organelles, potentially transforming drug discovery and cell‑based therapies.

Key Takeaways

• Two‑photon laser polymerizes photoresist inside living cells.
• Printed structures retain sub‑micron resolution.
• Cells survive, divide, and inherit printed objects.
• Technique enables intracellular devices for synthetic biology.
• Preliminary work, but promises novel therapeutic tools.

Pulse Analysis

The ability to fabricate objects inside a living cell marks a paradigm shift in biofabrication. Traditional 3D‑printing platforms operate ex vivo, requiring cells to be seeded onto scaffolds after printing. By contrast, the new two‑photon lithography method injects a biocompatible photoresist directly into the cytoplasm and solidifies it with a focused laser beam, achieving sub‑micron precision without compromising membrane integrity. This intracellular manufacturing bypasses external scaffolds and offers unprecedented control over spatial arrangement of synthetic components within the native cellular environment.

From a technical standpoint, the process leverages the nonlinear absorption of near‑infrared photons, enabling deep tissue penetration and localized polymerization. The photoresist formulation is engineered to be non‑toxic and to cure rapidly under femtosecond pulses, forming stable polymer networks that coexist with organelles. Remarkably, cells retain normal metabolic activity and can undergo mitosis, distributing the printed microstructures to progeny. This inheritance capability suggests that engineered traits could be propagated through cell lineages, a feature valuable for long‑term studies of cellular mechanics and for creating living materials with built‑in functionality.

Looking ahead, intracellular 3D‑printing could catalyze breakthroughs in synthetic biology, drug delivery, and regenerative medicine. Researchers envision embedding nanoscale sensors, actuators, or drug reservoirs that respond to intracellular cues, turning cells into programmable bio‑machines. Moreover, the technique may facilitate the construction of artificial organelles that augment metabolic pathways or confer resistance to disease. While ethical and safety considerations remain, especially regarding genome‑free modifications, the method provides a versatile platform for exploring cell‑level engineering without altering DNA, positioning it as a cornerstone technology for the next generation of cell‑based therapeutics.